Lv51
1410 积分 2023-03-30 加入
Generation of a potent anti-PD-L1-CD47 bispecific antibody with a strong therapeutic and safety profilecancer immunotherapy
6天前
已完结
Authorized manufacturing changes for therapeutic monoclonal antibodies (mAbs) in European Public Assessment Report (EPAR) documents
13天前
已完结
A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment
13天前
已完结
Small molecule epigenetic modulators for enhancingrecombinant antibody production in CHO cell cultures
17天前
已完结
Challenges to industrial mAb bioprocessing—removal of host cell proteins in CHO cell bioprocesses
17天前
已完结
First‑in‑human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors
18天前
已完结
Using MVDA with stoichiometric balances to optimize amino acid concentrations in chemically defined CHO cell culture medium for improved culture performance
1个月前
已完结
Enhanced harvest performance predictability through advanced multivariate data analysis of mammalian cell culture particle size distribution
1个月前
已完结
Multivariate data analysis of process parameters affecting the growth and productivity of stable Chinese hamster ovary cell pools expressing SARS-CoV-2 spike protein as vaccine antigen in early process development
1个月前
已完结
The new frontier in CHO cell line development: From random to targeted transgene integration technologies
2个月前
已完结
皖公网安备34019202002308
